Chronic Inflammation: Accelerator of Biological Aging

Biological aging is characterized by a chronic low-grade inflammation level. This chronic phenomenon has been named "inflamm-aging" and is a highly significant risk factor for morbidity and mortality in the older persons. The most common theories of inflamm-aging include redox stress, mitochondrial dysfunction, glycation, deregulation of the immune system, hormonal changes, epigenetic modifications, and dysfunction telomere attrition. Inflamm-aging plays a role in the initiation and progression of age-related diseases such as type II diabetes, Alzheimer's disease, cardiovascular disease, frailty, sarcopenia, osteoporosis, and cancer. This review will cover the identification of pathways that control age-related inflammation across multiple systems and its potential causal role in contributing to adverse health outcomes.

[1]  O. Lopez,et al.  Inflammatory Biomarkers Predict Domain-Specific Cognitive Decline in Older Adults , 2016, The journals of gerontology. Series A, Biological sciences and medical sciences.

[2]  I. Olsen.  The Oral Microbiome in Health and Disease , 2016 .

[3]  M. Cesari,et al.  Air Pollution modifies the association between successful and pathological aging throughout the frailty condition , 2015, Ageing Research Reviews.

[4]  S. Susen,et al.  Dietary CML-enriched protein induces functional arterial aging in a RAGE-dependent manner in mice. , 2015, Molecular nutrition & food research.

[5]  A. Shaw,et al.  Aging of the human innate immune system in HIV infection. , 2014, Current opinion in immunology.

[6]  C. Franceschi,et al.  Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.

[7]  F. Puisieux,et al.  Glycation: The angiogenic paradox in aging and age-related disorders and diseases , 2014, Ageing Research Reviews.

[8]  A. Simm,et al.  Role of advanced glycation end products in cellular signaling , 2014, Redox biology.

[9]  T. Harris,et al.  Myosteatosis and myofibrosis: relationship with aging, inflammation and insulin resistance. , 2013, Archives of gerontology and geriatrics.

[10]  Rahul Phadke,et al.  Acute skeletal muscle wasting in critical illness. , 2013, JAMA.

[11]  A. Boots,et al.  The influence of ageing on the development and management of rheumatoid arthritis , 2013, Nature Reviews Rheumatology.

[12]  Kajia Cao,et al.  Lamin B1 depletion in senescent cells triggers large-scale changes in gene expression and the chromatin landscape , 2013, Genes & development.

[13]  D. Bartlett,et al.  Understanding how we age: insights into inflammaging , 2013, Longevity & healthspan.

[14]  D. Blacker,et al.  The role of peripheral inflammatory markers in dementia and Alzheimer's disease: a meta-analysis. , 2013, The journals of gerontology. Series A, Biological sciences and medical sciences.

[15]  V. Dixit,et al.  Mechanisms of disease: inflammasome activation and the development of type 2 diabetes , 2013, Front. Immunol..

[16]  J. Campisi,et al.  Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. , 2013, The Journal of clinical investigation.

[17]  Teresa Oliveira,et al.  Biochemistry of adipose tissue: an endocrine organ , 2013, Archives of medical science : AMS.

[18]  M. Lederman,et al.  Residual immune dysregulation syndrome in treated HIV infection. , 2013, Advances in immunology.

[19]  A. Haley,et al.  Elevated Serum C-Reactive Protein Relates to Increased Cerebral Myoinositol Levels in Middle-Aged Adults , 2012, Cardiovascular psychiatry and neurology.

[20]  B. Baune,et al.  Depression and type 2 diabetes: Inflammatory mechanisms of a psychoneuroendocrine co-morbidity , 2012, Neuroscience & Biobehavioral Reviews.

[21]  R. Oppermann,et al.  Periodontal disease and systemic complications. , 2012, Brazilian oral research.

[22]  A. D. de Craen,et al.  Infection with cytomegalovirus but not herpes simplex virus induces the accumulation of late-differentiated CD4+ and CD8+ T-cells in humans. , 2011, The Journal of general virology.

[23]  B. Vaes,et al.  Associations Between Cytomegalovirus Infection and Functional Impairment and Frailty in the BELFRAIL Cohort , 2011, Journal of the American Geriatrics Society.

[24]  A. Traish,et al.  Dehydroepiandrosterone (DHEA)--a precursor steroid or an active hormone in human physiology. , 2011, The journal of sexual medicine.

[25]  R. Holmdahl,et al.  NOX2 complex-derived ROS as immune regulators. , 2011, Antioxidants & redox signaling.

[26]  D. Green,et al.  Mitochondria and the Autophagy–Inflammation–Cell Death Axis in Organismal Aging , 2011, Science.

[27]  A. Newman,et al.  Inflammatory markers in population studies of aging , 2011, Ageing Research Reviews.

[28]  R. Carey,et al.  Angiotensin II Type-2 receptors modulate inflammation through signal transducer and activator of transcription proteins 3 phosphorylation and TNFα production. , 2011, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[29]  S. Rubin,et al.  Cumulative Inflammatory Load Is Associated with Short Leukocyte Telomere Length in the Health, Aging and Body Composition Study , 2011, PloS one.

[30]  Antony Vinh,et al.  Inflammation, Immunity, and Hypertension , 2011, Hypertension.

[31]  M. Jensen,et al.  Fat tissue, aging, and cellular senescence , 2010, Aging cell.

[32]  J. Dowd,et al.  Cytomegalovirus antibody levels, inflammation, and mortality among elderly Latinos over 9 years of follow-up. , 2010, American journal of epidemiology.

[33]  Tanvir Ahmed,et al.  Assessment and management of nutrition in older people and its importance to health , 2010, Clinical interventions in aging.

[34]  N. Cook,et al.  A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women. , 2010, European heart journal.

[35]  G. Remuzzi,et al.  Angiotensin II revisited: new roles in inflammation, immunology and aging , 2010, EMBO molecular medicine.

[36]  M. Karin,et al.  Inflammation and oncogenesis: a vicious connection. , 2010, Current opinion in genetics & development.

[37]  J. Campisi,et al.  The senescence-associated secretory phenotype: the dark side of tumor suppression. , 2010, Annual review of pathology.

[38]  L. Ferrucci,et al.  Measuring systemic inflammatory regulation in older adults: evidence and utility. , 2009, Rejuvenation research.

[39]  T. Dawood,et al.  Mediators of target organ damage in hypertension: focus on obesity associated factors and inflammation. , 2009, Minerva cardioangiologica.

[40]  Paul M Ridker,et al.  Inflammation in atherosclerosis: from pathophysiology to practice. , 2009, Journal of the American College of Cardiology.

[41]  S. Rubin,et al.  Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength. , 2009, The journals of gerontology. Series A, Biological sciences and medical sciences.

[42]  B. Pedersen,et al.  Calprotectin — A Novel Marker of Obesity , 2009, PloS one.

[43]  J. Beckmann,et al.  Association between C-reactive protein and adiposity in women. , 2009, The Journal of clinical endocrinology and metabolism.

[44]  L. Ferrucci,et al.  Nonlinear multisystem physiological dysregulation associated with frailty in older women: implications for etiology and treatment. , 2009, The journals of gerontology. Series A, Biological sciences and medical sciences.

[45]  A. LaCroix,et al.  Inflammation and thrombosis biomarkers and incident frailty in postmenopausal women. , 2009, The American journal of medicine.

[46]  S. Shiesh,et al.  High Oxidative Stress Is Correlated with Frailty in Elderly Chinese , 2009, Journal of the American Geriatrics Society.

[47]  A. Greco,et al.  Frailty Syndrome is Associated with Altered Circulating Redox Balance and Increased Markers of Oxidative Stress , 2009, International journal of immunopathology and pharmacology.

[48]  D. Mozaffarian,et al.  Health effects of trans-fatty acids: experimental and observational evidence , 2009, European Journal of Clinical Nutrition.

[49]  G. Savva,et al.  Inflammation and frailty measures in older people , 2009, Journal of cellular and molecular medicine.

[50]  Jiahuai Han,et al.  Inflammatory signaling and cellular senescence. , 2009, Cellular signalling.

[51]  C. Luz,et al.  The Role of Stress Factors during Aging of the Immune System , 2009, Annals of the New York Academy of Sciences.

[52]  S. Anton,et al.  Molecular inflammation: Underpinnings of aging and age-related diseases , 2009, Ageing Research Reviews.

[53]  Dominick G. A. Burton.  Cellular senescence, ageing and disease , 2009, AGE.

[54]  Judith Campisi,et al.  Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor , 2008, PLoS biology.

[55]  Ahmad R. Hariri,et al.  Interleukin-6 Covaries Inversely with Hippocampal Grey Matter Volume in Middle-Aged Adults , 2008, Biological Psychiatry.

[56]  P. Lansdorp,et al.  Telomeres and Aging , 2008 .

[57]  B. Lamarche,et al.  Differential effect of atorvastatin and fenofibrate on plasma oxidized low-density lipoprotein, inflammation markers, and cell adhesion molecules in patients with type 2 diabetes mellitus. , 2008, Metabolism: clinical and experimental.

[58]  F. Marincola,et al.  Tumour immunity: effector response to tumour and role of the microenvironment , 2008, The Lancet.

[59]  P. Allavena,et al.  Pathways connecting inflammation and cancer. , 2008, Current opinion in genetics & development.

[60]  Hong Wang,et al.  Inflammation Activates the Interferon Signaling Pathways in Taste Bud Cells , 2007, The Journal of Neuroscience.

[61]  C. Lang,et al.  Protein kinase B/Akt: a nexus of growth factor and cytokine signaling in determining muscle mass. , 2007, Journal of applied physiology.

[62]  L. Fried,et al.  Insulin resistance and inflammation as precursors of frailty: the Cardiovascular Health Study. , 2007, Archives of internal medicine.

[63]  C. DeCarli,et al.  Inflammatory biomarkers are associated with total brain volume , 2007, Neurology.

[64]  Colm Cunningham,et al.  Systemic infections and inflammation affect chronic neurodegeneration , 2007, Nature Reviews Immunology.

[65]  G. Castellani,et al.  Inflammaging and anti-inflammaging: A systemic perspective on aging and longevity emerged from studies in humans , 2007, Mechanisms of Ageing and Development.

[66]  C. Caruso,et al.  The Genetics of Innate Immunity and Inflammation in Ageing, Age-Related Diseases and Longevity , 2007 .

[67]  Antonio Ceriello,et al.  The effects of diet on inflammation: emphasis on the metabolic syndrome. , 2006, Journal of the American College of Cardiology.

[68]  M. Visser,et al.  Inflammatory markers and loss of muscle mass (sarcopenia) and strength. , 2006, The American journal of medicine.

[69]  M. LeWinter,et al.  Immune activation is associated with reduced skeletal muscle mass and physical function in chronic heart failure. , 2006, International journal of cardiology.

[70]  Robert W. Taylor,et al.  High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease , 2006, Nature Genetics.

[71]  R. Leibel,et al.  CCR2 modulates inflammatory and metabolic effects of high-fat feeding. , 2006, The Journal of clinical investigation.

[72]  S. Cummings,et al.  Tumor necrosis factor-alpha polymorphism, bone strength phenotypes, and the risk of fracture in older women. , 2005, The Journal of clinical endocrinology and metabolism.

[73]  Claudio Franceschi,et al.  Innate immunity and inflammation in ageing: a key for understanding age-related diseases , 2005, Immunity & Ageing.

[74]  Nader Rifai,et al.  Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. , 2005, The Journal of nutrition.

[75]  J. Manson,et al.  Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction. , 2004, The American journal of clinical nutrition.

[76]  J. Flier,et al.  Adipose Tissue as an Endocrine Organ , 2014 .

[77]  J. Pickup.  Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. , 2004, Diabetes care.

[78]  R. Tracy,et al.  Emerging relationships of inflammation, cardiovascular disease and chronic diseases of aging , 2003, International Journal of Obesity.

[79]  P. Szlosarek,et al.  Tumour necrosis factor α: a potential target for the therapy of solid tumours , 2003 .

[80]  C. Luz,et al.  Impact of psychological and endocrine factors on cytokine production of healthy elderly people , 2003, Mechanisms of Ageing and Development.

[81]  C. Weyand,et al.  Immunosenescence, autoimmunity, and rheumatoid arthritis , 2003, Experimental Gerontology.

[82]  A. Yamashina,et al.  Increased pulse wave velocity associated with reduced calcaneal quantitative osteo-sono index: possible relationship between atherosclerosis and osteopenia. , 2003, The Journal of clinical endocrinology and metabolism.

[83]  N. Bryan,et al.  NO adducts in mammalian red blood cells: too much or too little? , 2003, Nature Medicine.

[84]  C. Harris,et al.  Radical causes of cancer , 2003, Nature Reviews Cancer.

[85]  K. Subbaramaiah,et al.  Cyclooxygenase 2: a molecular target for cancer prevention and treatment. , 2003, Trends in pharmacological sciences.

[86]  P. Szlosarek,et al.  Tumour necrosis factor alpha: a potential target for the therapy of solid tumours. , 2003, The Lancet. Oncology.

[87]  M. Fuente.  Effects of antioxidants on immune system ageing , 2002, European Journal of Clinical Nutrition.

[88]  A. Newman,et al.  Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. , 2002, The journals of gerontology. Series A, Biological sciences and medical sciences.

[89]  S. Weitzman,et al.  Chronic inflammation and cancer. , 2002, Oncology.

[90]  J. Wautier,et al.  AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expression. , 2002, Kidney international.

[91]  D. Sane,et al.  Arterial calcification: A review of mechanisms, animal models, and the prospects for therapy , 2001, Medicinal research reviews.

[92]  C. Franceschi,et al.  Inflamm‐aging: An Evolutionary Perspective on Immunosenescence , 2000 .

[93]  S. Manolagas,et al.  Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. , 2000, Endocrine reviews.

[94]  I. Kushner,et al.  Acute-phase proteins and other systemic responses to inflammation. , 1999, The New England journal of medicine.

[95]  P. Ridker,et al.  Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. , 1997, The New England journal of medicine.

[96]  Chawnshang Chang,et al.  Inhibition of NFκB Activity through Maintenance of IκBα Levels Contributes to Dihydrotestosterone-mediated Repression of the Interleukin-6 Promoter* , 1996, The Journal of Biological Chemistry.

[97]  E. Keller,et al.  Inhibition of NFkappaB activity through maintenance of IkappaBalpha levels contributes to dihydrotestosterone-mediated repression of the interleukin-6 promoter. , 1996, The Journal of biological chemistry.

[98]  C. Migeon,et al.  Dehydroepiandrosterone and androsterone levels in human plasma: effect of age and sex; day-to-day and diurnal variations. , 1957, The Journal of clinical endocrinology and metabolism.

[99]  L. Maillard,et al.  Action des acides amines sur les sucres : formation des melanoidines par voie methodique , 1912 .